Elevance Health Sees FY23 Adjusted EPS To Be Greater Than $33.00 Versus Prior Guidance Of Over $32.85 And Consensus Of $32.93.
Portfolio Pulse from Benzinga Newsdesk
Elevance Health has updated its FY23 adjusted EPS guidance to be greater than $33.00, up from the previous guidance of over $32.85 and consensus of $32.93.
October 18, 2023 | 10:06 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Elevance Health's updated FY23 adjusted EPS guidance is expected to positively impact its stock price in the short term.
Elevance Health's updated guidance indicates a better-than-expected financial performance for FY23. This positive outlook is likely to increase investor confidence and drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100